Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 4.4T | 4.3T | 3.4T | 2.8T |
Cost of revenue | 2.7T | 2.9T | 2.4T | 311.9B |
Gross profit | 1.7T | 1.5T | 1.0T | 2.4T |
Operating expense | ||||
Research & development | 107.2B | 109.6B | 106.6B | 92.1B |
Selling general and admin | — | 92.2B | 60.4B | 48.6B |
Other operating expenses | 854.0B | 549.4B | 426.7B | 231.3B |
Operating income | 7.7B | 100.8B | -71.4B | 1.5T |
Non operating interest income | ||||
Income | — | 26.1B | 12.5B | 6.3B |
Expense | 50.8B | 99.9B | 102.3B | 93.1B |
Other income expense | — | — | — | 191.6B |
Pretax income | 337.8B | 279.6B | 33.9B | -70.0B |
Tax provision | 105.0B | -38.5B | 7.0B | 42.3B |
Net income | 281.5B | 318.1B | 26.9B | -113.1B |
Basic EPS | — | 82.0 | 6.3 | -29.9 |
Diluted EPS | — | 81.9 | 6.3 | -29.9 |
Basic average shares | — | 3.3B | 3.3B | 3.3B |
Diluted average shares | — | 3.3B | 3.3B | 3.3B |
EBITDA | 626.7B | 674.0B | 378.8B | 253.2B |
Net income from continuing op. | 281.5B | 318.1B | 26.9B | -113.1B |
Minority interests | -3.2B | -4.1B | -2.8B | -1.3B |
Preferred stock dividends | 0 | 0 | 0 | 0 |